CoChat

The Antimicrobial Activity of Human Defensins at Physiological Non-Permeabilizing Concentrations Is Caused by the Inhibition of the Plasma Membrane H+-ATPases

Open access
Andrés, María T., Fierro, Patricia, Antuña, Victoria, Fierro, José F. · 2024 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 72 of the 74 references it cites were found in a registry or an index.

Abstract

Human defensins are cysteine-rich peptides (Cys-rich peptides) of the innate immune system. Defensins contain an ancestral structural motif (i.e., γ-core motif) associated with the antimicrobial activity of natural Cys-rich peptides. In this study, low concentrations of human α- and β-defensins showed microbicidal activity that was not associated with cell membrane permeabilization. The cell death pathway was similar to that previously described for human lactoferrin, also an immunoprotein containing a γ-core motif. The common features were (1) cell death not related to plasma membrane (PM) disruption, (2) the inhibition of microbicidal activity via extracellular potassium, (3) the influence of cellular respiration on microbicidal activity, and (4) the influence of intracellular pH on bactericidal activity. In addition, in yeast, we also observed (1) partial K+-efflux mediated via Tok1p K+-channels, (2) the essential role of mitochondrial ATP synthase in cell death, (3) the increment of intracellular ATP, (4) plasma membrane depolarization, and (5) the inhibition of external acidification mediated via PM Pma1p H+-ATPase. Similar features were also observed with BM2, an antifungal peptide that inhibits Pma1p H+-ATPase, showing that the above coincident characteristics were a consequence of PM H+-ATPase inhibition. These findings suggest, for the first time, that human defensins inhibit PM H+-ATPases at physiological concentrations, and that the subsequent cytosolic acidification is responsible for the in vitro microbicidal activity. This mechanism of action is shared with human lactoferrin and probably other antimicrobial peptides containing γ-core motifs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms25137335

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Antimicrobial and permeabilizing activities of human defensins. Microbicidal activity (blue lines) and membrane permeabilization (red lines) induced by defensins on C. albicans and P. aeruginosa cells. Cell suspensions (106 cells/mL) in Tris buffer were incubated for 90 min at 37 °C with the defensins (0 to 2 μM). The percentage of surviving cells (viability) with respect to the untreated control (100%) was determined by counting colony-forming units. The effect of defensins on membrane integrity was monitored by determining the percentage of propidium iodide (PI)-positive cells. Dashed lines indicate the non-permeabilizing inhibitory concentration (NPIC) for each defensin, as defined in the Results Section. The results are the means ± SD from duplicates of three independent experiments.
Figure 1 Antimicrobial and permeabilizing activities of human defensins. Microbicidal activity (blue lines) and membrane permeabilization (red lines) induced by defensins on C. albicans and P. aeruginosa cells. Cell suspensions (106 cells/mL) in Tris buffer were incubated for 90 min at 37 °C with the defensins (0 to 2 μM). The percentage of surviving cells (viability) with respect to the untreated control (100%) was determined by counting colony-forming units. The effect of defensins on membrane integrity was monitored by determining the percentage of propidium iodide (PI)-positive cells. Dashed lines indicate the non-permeabilizing inhibitory concentration (NPIC) for each defensin, as defined in the Results Section. The results are the means ± SD from duplicates of three independent experiments.CC BY · PubMed Central
Figure 2 Effect of microbicidal activity of human defensins on cellular K+-homeostasis. (A) Effect of extracellular K+ on candidacidal activity. The candidacidal activity of defensins (NPIC) was tested using a cellular suspension of C. albicans in Tris buffer in the presence or absence of 50 mM KCl. (B) K+-efflux induced in C. albicans cells incubated with defensins. K+-release was measured after incubation (90 min, 37 °C) with defensins and compared with the total cellular K+-content (100%) of untreated cells. (C) Effect of inhibition of the K+-channel Tok1p on the candidacidal activity of defensins. Cells were preincubated for 15 min at 37 °C with 10 mM TEA (Tok1p inhibitor) before the addition of the peptides (NPIC). (D) Effect of extracellular K+ on bactericidal activity of defensins. The bactericidal activity of defensins (NPIC) was tested using a cell suspension of P. aeruginosa in Tris buffer in the presence or absence of 50 mM KCl. A plate colony-counting method was used to determine the percentage of cell viability relative to the untreated control (100%). Human lactoferrin (hLf) and BM2 peptide or nystatin (Nys) and colistin (Cst) were used as positive or negative controls, respectively. Error bars represent the SD of the means determined from three independent experiments. Student’s t-test: * p < 0.05; ** p < 0.01; *** p < 0.001 relative to the control.
Figure 2 Effect of microbicidal activity of human defensins on cellular K+-homeostasis. (A) Effect of extracellular K+ on candidacidal activity. The candidacidal activity of defensins (NPIC) was tested using a cellular suspension of C. albicans in Tris buffer in the presence or absence of 50 mM KCl. (B) K+-efflux induced in C. albicans cells incubated with defensins. K+-release was measured after incubation (90 min, 37 °C) with defensins and compared with the total cellular K+-content (100%) of untreated cells. (C) Effect of inhibition of the K+-channel Tok1p on the candidacidal activity of defensins. Cells were preincubated for 15 min at 37 °C with 10 mM TEA (Tok1p inhibitor) before the addition of the peptides (NPIC). (D) Effect of extracellular K+ on bactericidal activity of defensins. The bactericidal activity of defensins (NPIC) was tested using a cell suspension of P. aeruginosa in Tris buffer in the presence or absence of 50 mM KCl. A plate colony-counting method was used to determine the percentage of cell viability relative to the untreated control (100%). Human lactoferrin (hLf) and BM2 peptide or nystatin (Nys) and colistin (Cst) were used as positive or negative controls, respectively. Error bars represent the SD of the means determined from three independent experiments. Student’s t-test: * p < 0.05; ** p < 0.01; *** p < 0.001 relative to the control.CC BY · PubMed Central
Figure 3 Influence of bioenergetic processes on the microbicidal activity of human defensins. (A) Viability of C. albicans cells treated with defensins (NPIC) in the presence of piericidin A (complex I inhibitor). (B) Viability of P. aeruginosa cells treated with the defensins HNP-1 or hBD-2 in the presence of piericidin A. In (A,B), cell suspensions (106 cells/mL) in Tris buffer were preincubated (for 15 min at 37 °C) with the inhibitor and then incubated with the defensins (NPIC). (C) Viability of fermenting L. lactis cells treated with a range of concentrations of HNP-1 (yellow bars) or hBD-2 (orange bars). The effect of defensins on membrane integrity was monitored by determining the percentage of propidium iodide (PI)-positive cells after treatment with HNP-1 (grey bars) or hBD-2 (dark bars). (D) Viability of P. aeruginosa cells treated with defensin HNP-1 or hBD-2 (NPIC) after preincubation (for 15 min at 37 °C) with 50 μM CCCP (protonophore). (E) Viability of P. aeruginosa cells treated with 50 μM CCCP alone at different extracellular pHs. (F) Viability of C. albicans cells treated with the defensins HNP-1 or hBD-2 in the presence of oligomycin A (mitochondrial ATP synthase inhibitor). Human lactoferrin (hLf) or BM2 peptide was used as a positive control. The percentage of cell viability relative to the untreated control (100%) was determined using a plate colony-counting method. Data are from at least three similar experiments, and bars indicate ± SD. Student’s t-test: * p < 0.05; ** p < 0.01; *** p < 0.001.
Figure 3 Influence of bioenergetic processes on the microbicidal activity of human defensins. (A) Viability of C. albicans cells treated with defensins (NPIC) in the presence of piericidin A (complex I inhibitor). (B) Viability of P. aeruginosa cells treated with the defensins HNP-1 or hBD-2 in the presence of piericidin A. In (A,B), cell suspensions (106 cells/mL) in Tris buffer were preincubated (for 15 min at 37 °C) with the inhibitor and then incubated with the defensins (NPIC). (C) Viability of fermenting L. lactis cells treated with a range of concentrations of HNP-1 (yellow bars) or hBD-2 (orange bars). The effect of defensins on membrane integrity was monitored by determining the percentage of propidium iodide (PI)-positive cells after treatment with HNP-1 (grey bars) or hBD-2 (dark bars). (D) Viability of P. aeruginosa cells treated with defensin HNP-1 or hBD-2 (NPIC) after preincubation (for 15 min at 37 °C) with 50 μM CCCP (protonophore). (E) Viability of P. aeruginosa cells treated with 50 μM CCCP alone at different extracellular pHs. (F) Viability of C. albicans cells treated with the defensins HNP-1 or hBD-2 in the presence of oligomycin A (mitochondrial ATP synthase inhibitor). Human lactoferrin (hLf) or BM2 peptide was used as a positive control. The percentage of cell viability relative to the untreated control (100%) was determined using a plate colony-counting method. Data are from at least three similar experiments, and bars indicate ± SD. Student’s t-test: * p < 0.05; ** p < 0.01; *** p < 0.001.CC BY · PubMed Central
Figure 4 Effect of defensins on the total ATP level, the electrical potential of the plasma membrane, and the glucose-induced external acidification in C. albicans. Cells were preincubated (for 15 min at 37 °C) with defensins (NPIC) or with other peptides [5 μM human lactoferrin (hLf), 0.25 μM BM2 peptide] used as positive controls. (A) Increment in ATP levels in C. albicans cells exposed to defensins. The percentage change in total cellular ATP after 30 min treatment with the peptides (NPIC) compared to the untreated control is shown. (B) Relative level of membrane electrical potential of C. albicans treated with defensins. Percentage of DiBAC4(3)-positive cells (depolarized cells) exposed to defensins relative to untreated control (100%). (C) Effect of defensins on glucose-dependent external acidification. Glucose was added to induce the proton pumping activity of Pma1p H+-ATPase as indicated with external acidification in control assays. HNP-1 (grey line), HNP-4 (orange line), hBD-2 (blue line), hBD-3 (green line), BM2 peptide (violet line), human lactoferrin (red line), and control (black line). Data are from at least three similar experiments, and bars indicate ± SD. In (C), only the mean data (n = 3) are shown, and the bars representing the ±SD (coefficient of variation of ≤10%) are omitted for clarity.
Figure 4 Effect of defensins on the total ATP level, the electrical potential of the plasma membrane, and the glucose-induced external acidification in C. albicans. Cells were preincubated (for 15 min at 37 °C) with defensins (NPIC) or with other peptides [5 μM human lactoferrin (hLf), 0.25 μM BM2 peptide] used as positive controls. (A) Increment in ATP levels in C. albicans cells exposed to defensins. The percentage change in total cellular ATP after 30 min treatment with the peptides (NPIC) compared to the untreated control is shown. (B) Relative level of membrane electrical potential of C. albicans treated with defensins. Percentage of DiBAC4(3)-positive cells (depolarized cells) exposed to defensins relative to untreated control (100%). (C) Effect of defensins on glucose-dependent external acidification. Glucose was added to induce the proton pumping activity of Pma1p H+-ATPase as indicated with external acidification in control assays. HNP-1 (grey line), HNP-4 (orange line), hBD-2 (blue line), hBD-3 (green line), BM2 peptide (violet line), human lactoferrin (red line), and control (black line). Data are from at least three similar experiments, and bars indicate ± SD. In (C), only the mean data (n = 3) are shown, and the bars representing the ±SD (coefficient of variation of ≤10%) are omitted for clarity.CC BY · PubMed Central
Figure 5 Schematic representation of the antibacterial mechanism of action proposed for the human defensins: Hypothetical defensin-induced cell death pathway in P. aeruginosa cells. The arrows indicate normal (green arrows), absent (white arrows), and involved (red arrows) ion fluxes. Involved ion fluxes would be part of the cell death pathway. The electrochemical proton gradient across the plasma membrane (PM) is generated by the electron transfer chain (ETC), and the re-entry of protons into the cytosol is used for various tasks, such as ATP synthesis (via F-type ATP synthase) or bacterial movement (via the flagellar rotor). Under these experimental conditions, the excess protons generated by active metabolism and gradually accumulating in the cytosol can be pumped out of the cell by the same F-type H+-ATPase, now operating in reverse mode and as an ATP-consuming ATP hydrolase (blue arrows). Defensins inhibit F-type H+-ATPase (1), preventing bidirectional proton flow through this functionally reversible H+-ATPase, thereby preventing intracellular pH regulation. Consequently, protons continuously pumped out of the cell via ETC activity hypothetically return to the cytosol (2) by various routes (flagellar rotor, H+-leak, etc.), but now they cannot be removed from the cytosol by reversion of H+-ATPase activity, and their progressive accumulation leads to lethal cytosolic acidification (3). This cell death pathway can be stopped at various levels through the use of appropriate inhibitors: high extracellular K+; piericidin A (inhibitor of type I NADH dehydrogenase of ETC); or CCCP, a protonophore that, at neutral or slightly alkaline extracellular pH, removes the excess protons accumulated in the cytosol and counteracts the lethal cytosolic acidification induced by defensin-mediated H+-ATPase inhibition. OM, outer membrane; PM, plasma membrane.
Figure 5 Schematic representation of the antibacterial mechanism of action proposed for the human defensins: Hypothetical defensin-induced cell death pathway in P. aeruginosa cells. The arrows indicate normal (green arrows), absent (white arrows), and involved (red arrows) ion fluxes. Involved ion fluxes would be part of the cell death pathway. The electrochemical proton gradient across the plasma membrane (PM) is generated by the electron transfer chain (ETC), and the re-entry of protons into the cytosol is used for various tasks, such as ATP synthesis (via F-type ATP synthase) or bacterial movement (via the flagellar rotor). Under these experimental conditions, the excess protons generated by active metabolism and gradually accumulating in the cytosol can be pumped out of the cell by the same F-type H+-ATPase, now operating in reverse mode and as an ATP-consuming ATP hydrolase (blue arrows). Defensins inhibit F-type H+-ATPase (1), preventing bidirectional proton flow through this functionally reversible H+-ATPase, thereby preventing intracellular pH regulation. Consequently, protons continuously pumped out of the cell via ETC activity hypothetically return to the cytosol (2) by various routes (flagellar rotor, H+-leak, etc.), but now they cannot be removed from the cytosol by reversion of H+-ATPase activity, and their progressive accumulation leads to lethal cytosolic acidification (3). This cell death pathway can be stopped at various levels through the use of appropriate inhibitors: high extracellular K+; piericidin A (inhibitor of type I NADH dehydrogenase of ETC); or CCCP, a protonophore that, at neutral or slightly alkaline extracellular pH, removes the excess protons accumulated in the cytosol and counteracts the lethal cytosolic acidification induced by defensin-mediated H+-ATPase inhibition. OM, outer membrane; PM, plasma membrane.CC BY · PubMed Central
Figure 6 Schematic representation of the antimicrobial mechanism of action proposed for the human defensins: Hypothetical defensin-induced cell death pathway in C. albicans cells. The arrows indicate normal (green arrows), absent (white arrows), and involved (red arrows) ion fluxes. Involved ion fluxes would be part of the cell death pathway. In yeast, the Pma1p H+-ATPase unidirectionally pumps protons out of the cytoplasm to create a proton gradient across the plasma membrane (PM) and for internal pH homeostasis. Under these experimental conditions, the inhibitory effect of defensins on the Pma1p H+-ATPase appears to lethally perturb cellular ion homeostasis in two hypothetical concatenated phases. In the cytosolic phase, protons generated by active metabolism are accumulated in the cytosol due to the inhibitory effect of defensins on Pma1p H+-ATPase (1). The subsequent depolarization of the plasma membrane opens the voltage-gated potassium channel Tok1p, allowing a passive K+-efflux from the cytosol (2). These cytosolic events lead to the mitochondrial phase, in which the previous cytosolic acidification (3) and K+-efflux could facilitate a loss of mitochondrial potassium ions, favored by the simultaneous re-entry of protons into the mitochondrial matrix by the K+/H+ antiporter (hypothetical) and the F-type H+-ATPase (functions as an ATP synthase, as an increase in ATP was observed) (4) and (5). Eventually, the accumulation of protons in the mitochondrial matrix leads to acidification of this compartment (6), resulting in cell death. This cell death pathway can be stopped at various levels through the use of appropriate inhibitors: high extracellular K+-concentration [36], TEA (inhibitor of Tok1p K+-channel), piericidin A (inhibitor of type I NADH dehydrogenase of ETC), and oligomycin A (inhibitor of mitochondrial H+-ATPase). PM, plasma membrane; OMM, outer mitochondrial membrane; IMS, intermembrane space; IMM, inner mitochondrial membrane.
Figure 6 Schematic representation of the antimicrobial mechanism of action proposed for the human defensins: Hypothetical defensin-induced cell death pathway in C. albicans cells. The arrows indicate normal (green arrows), absent (white arrows), and involved (red arrows) ion fluxes. Involved ion fluxes would be part of the cell death pathway. In yeast, the Pma1p H+-ATPase unidirectionally pumps protons out of the cytoplasm to create a proton gradient across the plasma membrane (PM) and for internal pH homeostasis. Under these experimental conditions, the inhibitory effect of defensins on the Pma1p H+-ATPase appears to lethally perturb cellular ion homeostasis in two hypothetical concatenated phases. In the cytosolic phase, protons generated by active metabolism are accumulated in the cytosol due to the inhibitory effect of defensins on Pma1p H+-ATPase (1). The subsequent depolarization of the plasma membrane opens the voltage-gated potassium channel Tok1p, allowing a passive K+-efflux from the cytosol (2). These cytosolic events lead to the mitochondrial phase, in which the previous cytosolic acidification (3) and K+-efflux could facilitate a loss of mitochondrial potassium ions, favored by the simultaneous re-entry of protons into the mitochondrial matrix by the K+/H+ antiporter (hypothetical) and the F-type H+-ATPase (functions as an ATP synthase, as an increase in ATP was observed) (4) and (5). Eventually, the accumulation of protons in the mitochondrial matrix leads to acidification of this compartment (6), resulting in cell death. This cell death pathway can be stopped at various levels through the use of appropriate inhibitors: high extracellular K+-concentration [36], TEA (inhibitor of Tok1p K+-channel), piericidin A (inhibitor of type I NADH dehydrogenase of ETC), and oligomycin A (inhibitor of mitochondrial H+-ATPase). PM, plasma membrane; OMM, outer mitochondrial membrane; IMS, intermembrane space; IMM, inner mitochondrial membrane.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 72 references

Cited by

See all 9

Metadata

Authors
Andrés, M. T., Fierro, P., Antuña, V., & Fierro, J. F.
Affiliations
Universidad de Oviedo (ES)
Corresponding author
Fierro, José F.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2024-07-04
Volume
25
Issue
13
Pages
7335
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4400324306
Cited by
8
References
74
Citations by year
2026: 4 · 2025: 2 · 2024: 2
FWCI
2.07
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Servicio para el Control de la Esterilización (SCE)/Laboratorio de Microbiología Oral (LMO) of the University of Oviedo (FUO-19-258, FUO-21-304, SV-03-FSCARRASCO)
  • Fundación Sira Carrasco para la Ayuda a la Fibrosis Quística (FUO-19-258, FUO-21-304, SV-03-FSCARRASCO)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
  • Life Sciences › Immunology and Microbiology › Immunology › Invertebrate Immune Response Mechanisms
Keywords
human defensins, antimicrobial peptides, plasma membrane depolarization, intracellular acidification, cell death mechanisms, potassium efflux, mitochondrial ATP synthase, intracellular ATP, cellular respiration, antifungal peptides, lactoferrin, innate immunity
MeSH terms
Anti-Infective Agents, Candida albicans, Cell Membrane, Cell Membrane Permeability, Proton-Translocating ATPases, Humans, Hydrogen-Ion Concentration, Lactoferrin, Microbial Sensitivity Tests, Potassium, Saccharomyces cerevisiae, Defensins, beta-Defensins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Antimicrobial Activity of Human Defensins at Physiological Non-Permeabilizing Concentrations Is Caused by the Inhibition of the Plasma Membrane H+-ATPases. https://app.cochat.ai/papers/10.3390/ijms25137335
The paper
Andrés, M. T., Fierro, P., Antuña, V., & Fierro, J. F. (2024). The Antimicrobial Activity of Human Defensins at Physiological Non-Permeabilizing Concentrations Is Caused by the Inhibition of the Plasma Membrane H+-ATPases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137335

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.